Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF alpha inhibition in early polymyalgia rheumatica (etanercept vs placebo)
2007-003009-28Phase 3Completed
- Sponsor
- Department of Rheumatology
- Start
- Jun 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in polymyalgia rheumatica (PMR) comparing Etanercept with Placebo (2 arms). Primary endpoint: Clinical and paraclinical outcomes including analgesic use. Started Jun 2007; status: completed.
02
Drugs
etanercept
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2007-003009-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003009-28.